1)American Academy of Sleep Medicine:International Classification of Sleep Disorders, 3rd ed(ICSD-3). American Academy of Sleep Medicine, Darien, 2014
2)Ohayon MM:Epidemiology of insomnia:what we know and what we still need to learn. Sleep Med Rev 6:97-111, 2002
3)Morin CM, LeBlanc M, Daley M, et al:Epidemiology of insomnia:prevalence, self-help treatments, consultations, and determinants of help-seeking behaviors. Sleep Med 7:123-130, 2006
4)Cénat JM, Blais-Rochette C, Kokou-Kpolou CK, et al:Prevalence of symptoms of depression, anxiety, insomnia, posttraumatic stress disorder, and psychological distress among populations affected by the COVID-19 pandemic:a systematic review and meta-analysis. Psychiatry Res 295:113599, 2021
5)Taquet M, Geddes JR, Husain M, et al:6-month neurological and psychiatric outcomes in 236,379 survivors of COVID-19:a retrospective cohort study using electronic health records. Lancet Psychiatry 8:416-427, 2021
6)Ozminkowski RJ, Wang S, Walsh JK:The direct and indirect costs of untreated insomnia in adults in the United States. Sleep 30:263-273, 2007
7)Wade AG:The societal costs of insomnia. Neuropsychiatr Dis Treat 7:1-18, 2010
8)Shahly V, Berglund PA, Coulouvrat C, et al:The associations of insomnia with costly workplace accidents and errors:results from the America Insomnia Survey. Arch Gen Psychiatry 69:1054-1063, 2012
9)Rosekind MR, Gregory KB:Insomnia risks and costs:health, safety, and quality of life. Am J Manag Care 16:617-626, 2010
10)Endicott J, Nee J, Harrison W, et al:Quality of Life Enjoyment and Satisfaction Questionnaire:a new measure. Psychopharmacol Bull 29:321-326, 1993
11)Stevanovic D:Quality of Life Enjoyment and Satisfaction Questionnaire-short form for quality of life assessments in clinical practice:a psychometric study. J Psychiatr Ment Health Nurs 18:744-750, 2011
12)田崎美弥子,中根允文:健康関連「生活の質」評価としてのWHOQOL.行動計量 25:76-80, 1998
13)池田俊,白岩健,五十嵐中,他:日本語版EQ-5D-5Lにおけるスコアリング法の開発.保健医療科学 64:47-55, 2015
14)Weaver TE, Laizner AM, Evans LK, et al:An instrument to measure functional status outcomes for disorders of excessive sleepiness. Sleep 20:835-843, 1997
15)Leger D, Scheuermaier K, Raffray T, et al:HD-16:a new quality of life instrument specifically designed for insomnia. Sleep Med 6:191-198, 2005
16)Kyle SD, Morgan K, Espie CA:Insomnia and health-related quality of life. Sleep Med Rev 14:69-82, 2010
17)Kyle SD, Crawford MR, Morgan K, et al:The Glasgow Sleep Impact Index(GSII):a novel patient-centred measure for assessing sleep-related quality of life impairment in Insomnia Disorder. Sleep Med 14:493-501, 2013
18)三島和夫,綾部直子:厚生労働科学研究費補助金・障害者対策総合研究事業「臨床評価指標を踏まえた睡眠障害の治療ガイドライン作成及び難治性の睡眠障害の治療法開発に関する研究(研究代表者:井上雄一)」平成26年度分担研究報告書.pp17-24, 2015
19)三島和夫(睡眠薬の適正使用及び減量・中止のための診療ガイドラインに関する研究班)編:睡眠薬の適正使用及び減量・中止のための診療ガイドラインに関する研究.厚生労働科学研究費補助金 障害者対策研究事業「睡眠薬の適正使用及び減量・中止のための診療ガイドラインに関する研究」平成24年度総括・分担研究報告書.pp1-12, 2013
20)Barker MJ, Greenwood KM, Jackson M, et al:Persistence of cognitive effects after withdrawal from long-term benzodiazepine use:a meta-analysis. Arch Clin Neuropsychol 19:437-454, 2004
21)Mishima K, DiBonaventura M, Gross H:The burden of insomnia in Japan. Nat Sci Sleep 7:1-11, 2015